 Conference Call Scheduled for Tuesday, June 15 at 11:30 AM EDT NORTHVALE, NJ ACCESSWIRE June 14, 2021 Elite Pharmaceuticals, Inc. Elite or the CompanyOTCBB:ELTP, a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ended March 31, 2021 Fiscal 2021. Consolidated revenues for Fiscal 2021 were 25.4 million, an increase of 7.4 million or approximately 41 from the comparable period of the prior fiscal year. 